Patents Assigned to Asrazeneca AB
  • Patent number: 7943776
    Abstract: The invention concerns a compound of the Formula (I), wherein Qa is heteroaryl and is substituted with halogeno; R1 and R2 are each hydrogen; and Qb is phenyl or heteroaryl, and Qb may optionally bear 1 or 2 substituents selected from hydroxy, halogeno and (1-6C)alkyl, or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: May 17, 2011
    Assignee: Asrazeneca AB
    Inventors: Dearg Sutherland Brown, John Graham Cumming, Ian Alun Nash